Heterogeneity of the tumorigenic phenotype expressed by Madin-Darby canine kidney cells

Comparative Medicine

Volumn 61, Issue 3, 2011, Pages 243-250

  Omeir, Romelda L ^a   Teferedegne, Belete ^a   Foseh, Gideon S ^a   Beren, Joel J ^a   Snoy, Philip J ^a   Brinster, Lauren R ^a   Cook, James L ^b   Peden, Keith ^a   Lewis Jr , Andrew M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CANCER INCIDENCE; CARCINOGENESIS; CARCINOGENICITY; CELL FUNCTION; CELL HETEROGENEITY; CELL IMMORTALIZATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; MADIN DARBY CANINE KIDNEY CELL; METASTASIS; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; QUANTITATIVE ASSAY; TISSUE CULTURE; TUMOR GROWTH; ANIMAL; CARCINOGEN TESTING; CELL LINE; CELL TRANSFORMATION; DOG; NEOPLASM; NUDE MOUSE; PATHOLOGY;

ANIMALS; CARCINOGENICITY TESTS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DOGS; MICE; MICE, NUDE; NEOPLASMS; PHENOTYPE;

EID: 84856002128     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. 2005. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci USA 102:16339-16344. (Pubitemid 41688915)
2. Cook JL, Miura TA, Ikle DN, Lewis AM Jr, Routes JM. 2003. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo. Cancer Res 63:3435-3443. (Pubitemid 36735906)
3. Das M, Sakul H, Kong J, Acland GM, Pelletier J. 2000. A set of canine interrepeat sequence PCR markers for high-throughput genotyping. Physiol Genomics 4:13-24. (Pubitemid 33676676)
4. Gaush CR, Hard WL, Smith TF. 1966. Characterization of an established line of canine kidney cells (MDCK). Proc Soc Exp Biol Med 122:931-935.
5. Gekle M, Wunsch S, Oberleithner H, Silbernagl S. 1994. Characterization of 2 MDCK cell subtypes as a model system to study principal cell and intercalated cell properties. Pflugers Arch 428:157-162. (Pubitemid 24238860)
6. Hennings H, Robinson VA, Michael DM, Pettit GR, Jung R, Yuspa SH. 1990. Development of an in vitro analogue of initiated mouse epidermis to study tumor promoters and antipromoters. Cancer Res 50:4794-4800. (Pubitemid 20230431)
7. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
8. Jorda M, Vinyals A, Marazuela A, Cubillo E, Olmeda D, Valero E, Cano A, Fabra A. 2007. ID1 is induced in MDCK epithelial cells by activated Erk-MAPK pathway in response to expression of the Snail and E47 transcription factors. Exp Cell Res 313:2389-2403. (Pubitemid 46891477)
9. Joyce JA, Pollard JW. 2009. Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239-252.
10. Kadono Y, Okada Y, Namiki M, Seiki M, Sato H. 1998. Transformation of epithelial Madin-Darby canine kidney cells with p60(v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness. Cancer Res 58:2240-2244. (Pubitemid 28232914)
11. Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, Harada S, Seiki M, Sato H. 2000. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19:1764-1771. (Pubitemid 30200982)
12. Leighton J, Brada Z, Estes LW, Justh G. 1969. Secretory activity and oncogenicity of a cell line (MDCK) derived from canine kidney. Science 163:472-473.
13. Leighton J, Estes LW, Mansukhani S, Brada Z. 1970. A cell line derived from normal dog kidney (MDCK) exhibiting qualities of papillary adenocarcinoma and of renal tubular epithelium. Cancer 26:1022-1028.
14. Lewis AM Jr, Alling DW, Banks SM, Soddu S, Cook JL. 1999. Evaluating virus-transformed cell tumorigenicity. J Virol Methods 79:41-50. (Pubitemid 29182789)
15. Lewis AM Jr, Cook JL. 1985. A new role for DNA virus early proteins in viral carcinogenesis. Science 227:15-20. (Pubitemid 15156214)
16. Lewis MG, Spector AA. 1981. Differences in types of prostaglandins produced by 2 MDCK canine kidney cell sublines. Prostaglandins 21:1025-1032. (Pubitemid 11010562)
17. Madin SH, Andriese PC, Darby NB. 1957. The in vitro cultivation of tissues of domestic and laboratory animals. Am J Vet Res 18:932-941.
18. Madin SH, Darby NB Jr. 1958. Established kidney cell lines of normal adult bovine and ovine origin. Proc Soc Exp Biol Med 98:574-576.
19. Manohar M, Orrison B, Peden K, Lewis AM Jr. 2008. Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice. Biologicals 36:65-72.
20. Medema JK, Meijer J, Kersten AJ, Horton R. 2006. Safety assessment of Madin-Darby canine kidney cells as vaccine substrate. Dev Biol (Basel) 123:243-250, discussion 265-266.
21. Meier KE, Snavely MD, Brown SL, Brown JH, Insel PA. 1983. α1- and β2-adrenergic receptor expression in the Madin-Darby canine kidney epithelial cell line. J Cell Biol 97:405-415.
22. Miller RG. 1973. Nonparametric estimators of the mean tolerance in bioassay. Biometrika 60:535-542.
23. Oberleithner H, Westphale HJ, Gassner B. 1991. Alkaline stress transforms Madin-Darby canine kidney cells. Pflugers Arch 419:418-420.
24. Pfaller W, Gstraunthaler G, Kersting U, Oberleithner H. 1989. Carbonic anhydrase activity in Madin-Darby canine kidney cells. Evidence for intercalated cell properties. Ren Physiol Biochem 12:328-337. (Pubitemid 20005099)
25. Polyak K, Haviv I, Campbell IG. 2009. Coevolution of tumor cells and their microenvironment. Trends Genet 25:30-38.
26. Polyak K, Weinberg RA. 2009. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9:265-273.
27. Richardson JC, Scalera V, Simmons NL. 1981. Identification of 2 strains of MDCK cells which resemble separate nephron tubule segments. Biochim Biophys Acta 673:26-36. (Pubitemid 11149428)
28. Rindler MJ, Chuman LM, Shaffer L, Saier MH Jr. 1979. Retention of differentiated properties in an established dog kidney epithelial cell line (MDCK). J Cell Biol 81:635-648. (Pubitemid 9202331)
29. Routes JM, Ryan JC, Ryan S, Nakamura M. 2001. MHC class I molecules on adenovirus E1A-expressing tumor cells inhibit NK cell killing but not NK cell-mediated tumor rejection. Int Immunol 13:1301-1307. (Pubitemid 32994530)
30. Rubin H. 2008. Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype. Proc Natl Acad Sci USA 105:6215-6221. (Pubitemid 351758326)
31. Schoenenberger CA, Zuk A, Kendall D, Matlin KS. 1991. Multilayering and loss of apical polarity in MDCK cells transformed with viral K-ras. J Cell Biol 112:873-889. (Pubitemid 21909635)
32. Simmons NL. 1982. Cultured monolayers of MDCK cells: a novel model system for the study of epithelial development and function. Gen Pharmacol 13:287-291. (Pubitemid 12053771)
33. Stiles CD, Desmond W, Chuman LM, Sato G, Saier MH. 1976. Growth control of heterologous tissue culture cells in the congenitally athymic nude mouse. Cancer Res 36:1353-1360.
34. Taghian A, Budach W, Zietman A, Freeman J, Gioioso D, Ruka W, Suit HD. 1993. Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice. Cancer Res 53:5012-5017. (Pubitemid 23326201)
35. Taub M, Chuman UB, Rindler L, Saier MJ, Jr MH, Sato G. 1981. Alterations in growth requirements of kidney epithelial cells in defined medium associated with malignant transformation. J Supramol Struct Cell Biochem 15:63-72. (Pubitemid 11090334)
36. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
37. Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890.
38. U HS, Boerner P, Rindler MJ, Chuman L, Saier MH Jr. 1985. Characterization of chemically and virally transformed variants of Madin-Darby canine kidney (MDCK) epithelial cells. J Cell Physiol 122:299-307. (Pubitemid 15164133)
39. United States of America Food and Drug Administration. [Internet]. 2005. Proceedings of the FDA Vaccines and Related Biological Products Advisory Committee meeting. [Cited 16 November 2005]. Available at: www.fda.gov/ohrms/ dockets/ac/05/transcripts/2005- 4188t1.pdf.
40. United States of America Food and Drug Administration. [Internet]. 2005. Proceedings of the FDA Vaccines and Related Biological Products Advisory Committee meeting. [Cited 16 November 2005]. Available at: www.fda.gov/ohrms/ dockets/ac/05/slides/5-4188S1-5.pdf.
41. United States of America Food and Drug Administration. [Internet]. 2005. Proceedings of the FDA Vaccines and Related Biological Products Advisory Committee meeting. [Cited 16 November 2005]. Available at: www.fda.gov/ohrms/ dockets/ac/05/slides/5-4188S1-6.pdf
42. Valentich JD. 1981. Morphological similarities between the dog kidney cell line MDCK and the mammalian cortical collecting tubule. Ann N Y Acad Sci 372:384-405. (Pubitemid 12175077)